Target Immobilization as a Strategy for NMR-Based Fragment Screening: Comparison of TINS, STD, and SPR for Fragment Hit Identification

被引:29
作者
Kobayashi, Masakazu [1 ]
Retra, Kim [2 ]
Figaroa, Francis [1 ]
Hollander, Johan G. [1 ]
Ab, Eiso [1 ]
Heetebrij, Robert J. [1 ]
Irth, Hubertus [2 ]
Siegal, Gregg [1 ,3 ]
机构
[1] ZoBio BV, NL-2333 CC Leiden, Netherlands
[2] Vrije Univ Amsterdam, Dept Chem & Pharmaceut Sci, Fac Sci, Amsterdam, Netherlands
[3] Leiden Univ, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands
关键词
fragment-based drug discovery; NMR; TINS; saturation transfer difference NMR; surface plasmon resonance; DRUG DISCOVERY; LIGAND-BINDING; INHIBITORS; APPLICABILITY; SPECTROSCOPY; VALIDATION; DESIGN; RANGE;
D O I
10.1177/1087057110375614
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Fragment-based drug discovery (FBD) has become a widely accepted tool that is complementary to high-throughput screening (HTS) in developing small-molecule inhibitors of pharmaceutical targets. Because a fragment campaign can only be as successful as the hit matter found, it is critical that the first stage of the process be optimized. Here the authors compare the 3 most commonly used methods for hit discovery in FBD: high concentration screening (HCS), solution ligand-observed nuclear magnetic resonance (NMR), and surface plasmon resonance (SPR). They selected the commonly used saturation transfer difference (STD) NMR spectroscopy and the proprietary target immobilized NMR screening (TINS) as representative of the array of possible NMR methods. Using a target typical of FBD campaigns, the authors find that HCS and TINS are the most sensitive to weak interactions. They also find a good correlation between TINS and STD for tighter binding ligands, but the ability of STD to detect ligands with affinity weaker than 1 mM K-D is limited. Similarly, they find that SPR detection is most suited to ligands that bind with K-D better than 1 mM. However, the good correlation between SPR and potency in a bioassay makes this a good method for hit validation and characterization studies. (Journal of Biomolecular Screening 2010:978-989)
引用
收藏
页码:978 / 989
页数:12
相关论文
共 30 条
[1]   Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors [J].
Antonysamy, Stephen S. ;
Aubol, Brandon ;
Blaney, Jeff ;
Browner, Michelle F. ;
Giannetti, Anthony M. ;
Harris, Seth F. ;
Hebert, Normand ;
Hendle, Joerg ;
Hopkins, Stephanie ;
Jefferson, Elizabeth ;
Kissinger, Charles ;
Leveque, Vincent ;
Marciano, David ;
McGee, Ethel ;
Najera, Isabel ;
Nolan, Brian ;
Tomimoto, Masaki ;
Torres, Eduardo ;
Wright, Tobi .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (09) :2990-2995
[2]   Fragment screening by biochemical assay [J].
Barker, John ;
Courtney, Steve ;
Hesterkamp, Thomas ;
Ullmann, Dirk ;
Whittaker, Mark .
EXPERT OPINION ON DRUG DISCOVERY, 2006, 1 (03) :225-236
[3]   Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening [J].
Boehm, HJ ;
Boehringer, M ;
Bur, D ;
Gmuender, H ;
Huber, W ;
Klaus, W ;
Kostrewa, D ;
Kuehne, H ;
Luebbers, T ;
Meunier-Keller, N .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (14) :2664-2674
[4]   A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design [J].
Card, GL ;
Blasdel, L ;
England, BP ;
Zhang, C ;
Suzuki, Y ;
Gillette, S ;
Fong, D ;
Ibrahim, PN ;
Artis, DR ;
Bollag, G ;
Milburn, MV ;
Kim, SH ;
Schlessinger, J ;
Zhang, KYJ .
NATURE BIOTECHNOLOGY, 2005, 23 (02) :201-207
[5]   WaterLOGSY as a method for primary NMR screening: Practical aspects and range of applicability [J].
Dalvit, C ;
Fogliatto, G ;
Stewart, A ;
Veronesi, M ;
Stockman, B .
JOURNAL OF BIOMOLECULAR NMR, 2001, 21 (04) :349-359
[6]   Fluorine-NMR experiments for high-throughput screening: Theoretical aspects, practical considerations, and range of applicability [J].
Dalvit, C ;
Fagerness, PE ;
Hadden, DTA ;
Sarver, RW ;
Stockman, BJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (25) :7696-7703
[7]   NMR methods in fragment screening: theory and a comparison with other biophysical techniques [J].
Dalvit, Claudio .
DRUG DISCOVERY TODAY, 2009, 14 (21-22) :1051-1057
[8]   Virtual exploration of the chemical universe up to 11 atoms of C, N, O, F: Assembly of 26.4 million structures (110.9 million stereoisomers) and analysis for new ring systems, stereochemistry, physicochemical properties, compound classes, and drug discovery [J].
Fink, Tobias ;
Reymond, Jean-Louis .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2007, 47 (02) :342-353
[9]  
Fruh V., 2008, FRAGMENT BASED DRUG, P135
[10]   Druggability indices for protein targets derived from NMR-based screening data [J].
Hajduk, PJ ;
Huth, JR ;
Fesik, SW .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (07) :2518-2525